• Blog
  • Pricing
  • Contact
  • FAQ
Sign InSign Up
AI Agent for Financial MarketsAsk anything. Our AI Agent brings real-time data and full market coverage.Open chat
MarketsStocksCryptoForexCommoditiesCalendarInsiders
CTXR

CTXR

Citius Pharmaceuticals, Inc.

NASDAQHealthcareBiotechnologyUS

USD0.58

-0.02 (-3.81%)

Rating:B-

Company Profile

CEO

Leonard L. Mazur

IPO Date

2014-10-02

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

Country

US

Market Metrics

Open

$0.59

Prev. Close

$0.60

Day Low

$0.57

Day High

$0.61

52W Low

$0.48

52W High

$2.48

Market Cap

$0.01B

Volume

0.29M

OverviewFinancialsRatingsInsidersSentimentsChart Patterns
News SentimentNeutral

Articles

10

Avg Positive

12.5%

Avg Negative

8.5%

Avg Neutral

79.2%

News Feed

Best Penny Stocks For Your Buy List in September? 3 To Watch

PennyStocks·8/31/2021·↓ negative

Citius Pharmaceuticals, Inc. Reports Third Fiscal Quarter 2021 Financial Results and Provides General Business Update

PRNewsWire·8/12/2021·↑ positive

Citius Pharmaceuticals Addresses Unmet Needs for Patients with CVCs

Benzinga·8/4/2021·↓ negative

Could Citius Pharmaceuticals Be a Millionaire-Maker Stock?

The Motley Fool·7/20/2021·↑ positive

3 Penny Stocks That Are Popular With Reddit Traders Right Now

PennyStocks·7/15/2021·↑ positive

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Citius Pharmaceuticals, Inc. - CTXR

PRNewsWire·7/7/2021·↓ negative

Citius Pharmaceuticals, Inc. Provides First Half 2021 Business Update, Highlights Upcoming Milestones

PRNewsWire·7/7/2021·↑ positive

Are Options Traders Betting on a Big Move in Citius Pharmaceuticals (CTXR) Stock?

Zacks Investment Research·7/7/2021·↓ negative

Here's Why Citius Pharmaceuticals Stock Is Losing Ground Today

The Motley Fool·7/1/2021·↑ positive

Is It Too Late to Buy Citius Pharmaceuticals Stock?

The Motley Fool·6/23/2021·↑ positive